Other drugs, like Zepbound, may be more effective for some patients.
Ongoing laboratory studies continue to evaluate how antioxidant systems contribute to cellular maintenance, signaling pathways, and biological function
However, it is now clear that the portfolio of GLP-1 drugs will remain in shortage for some amount of time and at Hims & Hers, we believe any amount of time is too long to wait for the care you deserve and the treatments you need
The current trial phase and status can be verified via ClinicalTrials.gov or the EU Clinical Trials Register
GLP-1 pens need to stay cold
Most patients notice effects indirectly: sustained energy without blood sugar crashes, reduced bloating, or accelerated inch loss when combined with caloric deficit